Tested Applications
| Positive WB detected in | HeLa cells |
| Positive IF/ICC detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
25643-1-AP targets VNN2 in WB, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag22345 Product name: Recombinant human VNN2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 448-520 aa of BC126145 Sequence: EIHLSPGKFEVLKDGRLVNKNGSSGPILTVSLFGRWYTKDSLYSSCGTSNSAITYLLIFILLMIIALQNIVML Predict reactive species |
| Full Name | vanin 2 |
| Calculated Molecular Weight | 520 aa, 59 kDa |
| Observed Molecular Weight | 33 kDa |
| GenBank Accession Number | BC126145 |
| Gene Symbol | VNN2 |
| Gene ID (NCBI) | 8875 |
| RRID | AB_2880173 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O95498 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for VNN2 antibody 25643-1-AP | Download protocol |
| WB protocol for VNN2 antibody 25643-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The VNN2 Polyclonal antibody (Cat# 25643-1-AP) has 2 citations. These appear in Journal of the European Academy of Dermatology and Venereology and Oncology Reports. The cited research spans dermatology (proteomic analysis of verrucous epidermal naevi in children) and oncology (microRNA regulation of osteosarcoma cell proliferation and invasion via VNN2 targeting).
| Species | Application | Title |
|---|---|---|
J Eur Acad Dermatol Venereol Differentially expressed proteins identified by TMT proteomics analysis in children with verrucous epidermal naevi. | ||
Oncol Rep MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2. |



